Publication | Closed Access

Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen–positive chronic hepatitis B patients

Hepatic DisordersAutoimmune DiseaseHepatologyViral HepatitisImmunologyHepatitis BHepatitisAutoantigensHumoral ImmunityChronic Viral InfectionMedicineAdd-on Therapy